Heramed Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -3.359x

Heramed Ltd cash flow conversion efficiency. Based on the latest financial reports, Heramed Ltd (HMD) has a cash flow conversion efficiency ratio of -3.359x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.27 Million ≈ $-901.06K USD) by net assets (AU$379.12K ≈ $268.26K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Heramed Ltd (2016–2024)

Cash flow conversion efficiency of Heramed Ltd from 2016 to 2024. This chart illustrates how Heramed Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Heramed Ltd for real-time trading data and today's change.

Heramed Ltd Cash Flow Conversion Ratio Explained

Heramed Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Heramed Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Heramed Ltd ranked by their cash flow conversion efficiency. Also see market cap of Heramed Ltd for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Trisula Textile Industries Tbk PT JK:BELL	0.074x
MetalsTech Limited F:MT1	-0.085x
Verimatrix PA:VMX	-0.012x
Quickstep Holdings Ltd AU:QHL	2.197x
Lii Hen Industries Bhd KLSE:7089	0.033x
Yong Shun Chemical Co Ltd TWO:4711	-0.020x
CORESTATE Capital Holding S.A F:CCAP	N/A
Hyundai Engineering & Construction Co Ltd KO:000725	-0.051x

Annual Cash Flow Conversion Efficiency for Heramed Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Heramed Ltd from 2016 to 2024. Review financial flexibility index of Heramed Ltd to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$1.72 Million ≈ $1.21 Million	AU$-4.81 Million ≈ $-3.41 Million	-2.807x	+76.49%
2023-12-31	AU$466.70K ≈ $330.22K	AU$-5.57 Million ≈ $-3.94 Million	-11.940x	-1249.49%
2022-12-31	AU$2.89 Million ≈ $2.05 Million	AU$-2.56 Million ≈ $-1.81 Million	-0.885x	+87.90%
2021-12-31	AU$441.88K ≈ $312.66K	AU$-3.23 Million ≈ $-2.29 Million	-7.314x	-422.60%
2020-12-31	AU$1.99 Million ≈ $1.41 Million	AU$-2.78 Million ≈ $-1.97 Million	-1.399x	-21.16%
2019-12-31	AU$2.39 Million ≈ $1.69 Million	AU$-2.76 Million ≈ $-1.95 Million	-1.155x	-183.85%
2018-12-31	AU$3.36 Million ≈ $2.37 Million	AU$-1.37 Million ≈ $-966.34K	-0.407x	+85.05%
2017-12-31	AU$201.88K ≈ $142.84K	AU$-549.66K ≈ $-388.92K	-2.723x	-71.31%
2016-12-31	AU$872.17K ≈ $617.12K	AU$-1.39 Million ≈ $-980.81K	-1.589x	--

About Heramed Ltd

AU:HMD Australia Medical Devices

Market Cap

$29.16 Million

AU$41.21 Million AUD

Market Cap Rank

#23641 Global

#896 in Australia

Share Price

AU$0.04

Change (1 day)

+0.00%

52-Week Range

AU$0.03 - AU$0.05

All Time High

AU$0.32